Circulation Research · 2010 · 133 citations · 33 references
MedicineCardiologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionApoptotic SignalingCardiovascular Molecular PhysiologyHeart FailureIschemic Heart DiseaseMyocardial ProtectionAdrenergic Receptor SignalingG Protein-coupled Receptor Kinase RegulationG Protein-coupled Receptor Kinase SignalingHeart Failure Molecular MechanismsMyocardial Ischemic EventsNitric OxideNitric Oxide ModulationProtein Kinase G Signaling
RATIONALE: Activation of prosurvival kinases and subsequent nitric oxide (NO) production by certain G protein-coupled receptors (GPCRs) protects myocardium in ischemia/reperfusion injury (I/R) models. GPCR signaling pathways are regulated by GPCR kinases (GRKs), and GRK2 has been shown to be a critical molecule in normal and pathological cardiac function. OBJECTIVE: A loss of cardiac GRK2 activity is known to arrest progression of heart failure (HF), at least in part by normalization of cardiac β-adrenergic receptor (βAR) signaling. Chronic HF studies have been performed with GRK2 knockout mice, as well as expression of the βARKct, a peptide inhibitor of GRK2 activity. This study was conducted to examine the role of GRK2 and its activity during acute myocardial ischemic injury using an I/R model. METHODS AND RESULTS: We demonstrate, using cardiac-specific GRK2 and βARKct-expressing transgenic mice, a deleterious effect of GRK2 on in vivo myocardial I/R injury with βARKct imparting cardioprotection. Post-I/R infarct size was greater in GRK2-overexpressing mice (45.0±2.8% versus 31.3±2.3% in controls) and significantly smaller in βARKct mice (16.8±1.3%, P<0.05). Importantly, in vivo apoptosis was found to be consistent with these reciprocal effects on post-I/R myocardial injury when levels of GRK2 activity were altered. Moreover, these results were reflected by higher Akt activation and induction of NO production via βARKct, and these antiapoptotic/survival effects could be recapitulated in vitro. Interestingly, selective antagonism of β(2)ARs abolished βARKct-mediated cardioprotection, suggesting that enhanced GRK2 activity on this GPCR is deleterious to cardiac myocyte survival. CONCLUSION: The novel effect of reducing acute ischemic myocardial injury via increased Akt activity and NO production adds significantly to the therapeutic potential of GRK2 inhibition with the βARKct not only in chronic HF but also potentially in acute ischemic injury conditions.
33
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
David Fulton, Jean‐Philippe Gratton, Timothy J. McCabe et al. · Nature · 1999 · 2.6K citations
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
Walter J. Koch, Howard A. Rockman, Philippe Samama et al. · Science · 1995 · 715 citations
Medicine, Cardiology, Pharmacology +17